Literature DB >> 33409640

Anti-leishmanial and anti-trypanosomal natural products from endophytes.

Jean Baptiste Hzounda Fokou1,2, Darline Dize3, Gisele Marguerite Etame Loe4, Moise Henri Julien Nko'o4, Jean Pierre Ngene4, Charles Christian Ngoule4, Fabrice Fekam Boyom3.   

Abstract

Leishmania spp. and Trypanosoma cruzi are parasites belonging to the Trypanosomatidae family and the causative agents for two very important neglected tropical diseases (NTDs), namely leishmaniasis and trypanosomiasis, respectively. Together, they affect millions of people worldwide and the number of cases is constantly rising; thus, further effort on identifying and developing non-toxic, affordable and effective new drug is urgently needed to overcome this alarming situation. Exploring natural products from fungal and bacterial origin remains hitherto a valuable approach to find new hits and candidates for the development of new drugs against these protozoal human infections. Endophytes, which are microorganisms (fungal and bacterial) inhabiting plant tissues, represent a promising source, as they hold potential to produce a high number of distinct chemical scaffolds. These structurally diverse natural products have previously been successfully tested against a wide range of pathogenic microorganisms. The present review provides an update of endophytic compounds exerting anti-trypanosomal and anti-leishmanial effects and their predicted pharmacokinetic properties.

Entities:  

Keywords:  Endophytes; Leishmania spp.; Natural products; Pharmacokinetic; Trypanosoma cruzi

Mesh:

Substances:

Year:  2021        PMID: 33409640     DOI: 10.1007/s00436-020-07035-1

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  31 in total

Review 1.  Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).

Authors:  José A Castro; Maria Montalto de Mecca; Laura C Bartel
Journal:  Hum Exp Toxicol       Date:  2006-08       Impact factor: 2.903

2.  Trypanosoma cruzi: mechanisms of cell-invasion and intracellular survival.

Authors:  N W Andrews; S Schenkman; V Ley; M B Whitlow; E S Robbins; V Nussenzweig
Journal:  Mem Inst Oswaldo Cruz       Date:  1988-11       Impact factor: 2.743

Review 3.  The Trypanosoma cruzi-host-cell interplay: location, invasion, retention.

Authors:  Luciana O Andrade; Norma W Andrews
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

Review 4.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 5.  Protease inhibitors in potential drug development for Leishmaniasis.

Authors:  Partha Das; Md Nur Alam; Dibyendu Paik; Kanchan Karmakar; Tripti De; Tapati Chakraborti
Journal:  Indian J Biochem Biophys       Date:  2013-10       Impact factor: 1.918

Review 6.  Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.

Authors:  Thomas P C Dorlo; Manica Balasegaram; Jos H Beijnen; Peter J de Vries
Journal:  J Antimicrob Chemother       Date:  2012-07-24       Impact factor: 5.790

7.  Altenusin, a biphenyl isolated from the endophytic fungus Alternaria sp., inhibits trypanothione reductase from Trypanosoma cruzi.

Authors:  Betania Barros Cota; Luiz Henrique Rosa; Rachel Basques Caligiorne; Ana Lúcia Teles Rabello; Tânia Maria Almeida Alves; Carlos Augusto Rosa; Carlos Leomar Zani
Journal:  FEMS Microbiol Lett       Date:  2008-06-28       Impact factor: 2.742

8.  Leishmaniasis worldwide and global estimates of its incidence.

Authors:  Jorge Alvar; Iván D Vélez; Caryn Bern; Mercé Herrero; Philippe Desjeux; Jorge Cano; Jean Jannin; Margriet den Boer
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

9.  Leishmanicidal compounds of Nectria pseudotrichia, an endophytic fungus isolated from the plant Caesalpinia echinata (Brazilwood).

Authors:  Betania Barros Cota; Luiza Guimarães Tunes; Daniela Nabak Bueno Maia; Jonas Pereira Ramos; Djalma Menezes de Oliveira; Markus Kohlhoff; Tânia Maria de Almeida Alves; Elaine Maria Souza-Fagundes; Fernanda Fraga Campos; Carlos Leomar Zani
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02       Impact factor: 2.743

Review 10.  Management of trypanosomiasis and leishmaniasis.

Authors:  Michael P Barrett; Simon L Croft
Journal:  Br Med Bull       Date:  2012-11-07       Impact factor: 4.291

View more
  1 in total

Review 1.  Plant Terpenoids as Hit Compounds against Trypanosomiasis.

Authors:  Raquel Durão; Cátia Ramalhete; Ana Margarida Madureira; Eduarda Mendes; Noélia Duarte
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.